1 Min Read
Dec 19 (Reuters) - Kancera AB :
* Reports positive results with fractalkine blocker KAN0440567 in preclinical models of pain caused by anti-cancer drugs
Source text for Eikon:
Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.